Cargando…
SARS-CoV-2 variants in severely symptomatic and deceased persons who had been vaccinated against COVID-19 in São Paulo, Brazil
COVID-19 vaccination began in São Paulo, Brazil in January 2021, first targeting healthcare workers (HCWs) and the elderly, using the CoronaVac vaccine (Sinovac/Butantan) and subsequently the Oxford/AstraZeneca (ChAdOx1) vaccine (AstraZeneca/FIOCRUZ-RJ). Studies on such vaccines have shown efficacy...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Organización Panamericana de la Salud
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8544615/ https://www.ncbi.nlm.nih.gov/pubmed/34707647 http://dx.doi.org/10.26633/RPSP.2021.126 |
_version_ | 1784589854110121984 |
---|---|
author | Campos, Karoline Rodrigues Sacchi, Cláudio Tavares Abbud, Adriano Caterino-de-Araujo, Adele |
author_facet | Campos, Karoline Rodrigues Sacchi, Cláudio Tavares Abbud, Adriano Caterino-de-Araujo, Adele |
author_sort | Campos, Karoline Rodrigues |
collection | PubMed |
description | COVID-19 vaccination began in São Paulo, Brazil in January 2021, first targeting healthcare workers (HCWs) and the elderly, using the CoronaVac vaccine (Sinovac/Butantan) and subsequently the Oxford/AstraZeneca (ChAdOx1) vaccine (AstraZeneca/FIOCRUZ-RJ). Studies on such vaccines have shown efficacy in preventing severe cases and deaths, but there is a lack of information regarding their effectiveness. This manuscript presents data from the Instituto Adolfo Lutz (IAL), a public health laboratory located in São Paulo City that receives samples from 17 Regional Health Departments under the Secretary of Health of São Paulo, for SARS-CoV-2 genomic surveillance. Through May 15, 2021 IAL received 20 samples for analysis from COVID-19 vaccinated individuals who needed hospitalization and/or died from COVID-19. Next-generation sequencing was performed on an Ion Torrent S5 platform using the AmpliSeq™ SARS-CoV-2 kit. Almost all cases were vaccinated with CoronaVac and presented the gamma variant of concern (VOC). Cases of death were observed mostly in the elderly in nursing homes, and severe cases in younger frontline HCWs. This data confirmed that the SARS-CoV-2 gamma variant is highly transmissible, severe, and lethal for COVID-19 in these groups of individuals, thereby highlighting the importance of continuous vaccination and non-pharmacological prevention measures to avoid virus dissemination and the emergence of new VOCs. |
format | Online Article Text |
id | pubmed-8544615 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Organización Panamericana de la Salud |
record_format | MEDLINE/PubMed |
spelling | pubmed-85446152021-10-26 SARS-CoV-2 variants in severely symptomatic and deceased persons who had been vaccinated against COVID-19 in São Paulo, Brazil Campos, Karoline Rodrigues Sacchi, Cláudio Tavares Abbud, Adriano Caterino-de-Araujo, Adele Rev Panam Salud Publica Short Communication COVID-19 vaccination began in São Paulo, Brazil in January 2021, first targeting healthcare workers (HCWs) and the elderly, using the CoronaVac vaccine (Sinovac/Butantan) and subsequently the Oxford/AstraZeneca (ChAdOx1) vaccine (AstraZeneca/FIOCRUZ-RJ). Studies on such vaccines have shown efficacy in preventing severe cases and deaths, but there is a lack of information regarding their effectiveness. This manuscript presents data from the Instituto Adolfo Lutz (IAL), a public health laboratory located in São Paulo City that receives samples from 17 Regional Health Departments under the Secretary of Health of São Paulo, for SARS-CoV-2 genomic surveillance. Through May 15, 2021 IAL received 20 samples for analysis from COVID-19 vaccinated individuals who needed hospitalization and/or died from COVID-19. Next-generation sequencing was performed on an Ion Torrent S5 platform using the AmpliSeq™ SARS-CoV-2 kit. Almost all cases were vaccinated with CoronaVac and presented the gamma variant of concern (VOC). Cases of death were observed mostly in the elderly in nursing homes, and severe cases in younger frontline HCWs. This data confirmed that the SARS-CoV-2 gamma variant is highly transmissible, severe, and lethal for COVID-19 in these groups of individuals, thereby highlighting the importance of continuous vaccination and non-pharmacological prevention measures to avoid virus dissemination and the emergence of new VOCs. Organización Panamericana de la Salud 2021-10-25 /pmc/articles/PMC8544615/ /pubmed/34707647 http://dx.doi.org/10.26633/RPSP.2021.126 Text en https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs 3.0 IGO License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited. No modifications or commercial use of this article are permitted. In any reproduction of this article there should not be any suggestion that PAHO or this article endorse any specific organization or products. The use of the PAHO logo is not permitted. This notice should be preserved along with the article’s original URL. Open access logo and text by PLoS, under the Creative Commons Attribution-Share Alike 3.0 Unported license. |
spellingShingle | Short Communication Campos, Karoline Rodrigues Sacchi, Cláudio Tavares Abbud, Adriano Caterino-de-Araujo, Adele SARS-CoV-2 variants in severely symptomatic and deceased persons who had been vaccinated against COVID-19 in São Paulo, Brazil |
title | SARS-CoV-2 variants in severely symptomatic and deceased persons who had been vaccinated against COVID-19 in São Paulo, Brazil |
title_full | SARS-CoV-2 variants in severely symptomatic and deceased persons who had been vaccinated against COVID-19 in São Paulo, Brazil |
title_fullStr | SARS-CoV-2 variants in severely symptomatic and deceased persons who had been vaccinated against COVID-19 in São Paulo, Brazil |
title_full_unstemmed | SARS-CoV-2 variants in severely symptomatic and deceased persons who had been vaccinated against COVID-19 in São Paulo, Brazil |
title_short | SARS-CoV-2 variants in severely symptomatic and deceased persons who had been vaccinated against COVID-19 in São Paulo, Brazil |
title_sort | sars-cov-2 variants in severely symptomatic and deceased persons who had been vaccinated against covid-19 in são paulo, brazil |
topic | Short Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8544615/ https://www.ncbi.nlm.nih.gov/pubmed/34707647 http://dx.doi.org/10.26633/RPSP.2021.126 |
work_keys_str_mv | AT camposkarolinerodrigues sarscov2variantsinseverelysymptomaticanddeceasedpersonswhohadbeenvaccinatedagainstcovid19insaopaulobrazil AT sacchiclaudiotavares sarscov2variantsinseverelysymptomaticanddeceasedpersonswhohadbeenvaccinatedagainstcovid19insaopaulobrazil AT abbudadriano sarscov2variantsinseverelysymptomaticanddeceasedpersonswhohadbeenvaccinatedagainstcovid19insaopaulobrazil AT caterinodearaujoadele sarscov2variantsinseverelysymptomaticanddeceasedpersonswhohadbeenvaccinatedagainstcovid19insaopaulobrazil |